Bioavailability and Bioequivalence Study of ER Torsemide and Spironolactone FDC Tablet in Healthy Subjects
Clinical trial NCT07015671 · COMPLETED
Trial details
- NCT number
- NCT07015671
- Sponsor
- Sarfez Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-01
- Primary completion
- 2025-12-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.